Skip to main content

Month: September 2021

POET Technologies Ships First Optical Engines Samples to Customers

TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (TSX Venture: PTK; OTCQX: POETF), the designer and developer of the POET Optical Interposer™ and Photonic Integrated Circuits (PICs) for the data center and tele-communication markets, today reported that the Company has shipped its first 100G Transmit (Tx) Optical Engine sample to a leading European optical systems company. The Company also confirmed that additional samples will be delivered to several other interested companies over the next month.   Several prospective customers are expected to participate in POET’s demonstrations of its Optical Interposer-based optical engine solutions this week, concurrent with the CIOE conference in Shenzhen. The sample delivered to a leading European optical systems company supports a combined transmit...

Continue reading

TSX Approves ECN Capital’s Normal Course Issuer Bids for Common Shares and Preferred Shares

TORONTO, Sept. 14, 2021 (GLOBE NEWSWIRE) — ECN Capital Corp. (TSX: ECN, ECN.PR.A, ECN.PR.C) (“ECN Capital” or the “Company”) today announced that the Toronto Stock Exchange (the “TSX”) has approved the Company’s notice of intention to commence a normal course issuer bid (the “Common Share Bid”) for common shares of the Company (the “Common Shares”) and a normal course issuer bid (the “Preferred Share Bid” and, together with the Common Share Bid, the “Bids”) for the Company’s Series A 6.50% Rate Reset Preferred Shares (the “Series A Preferred Shares”) and Series C 6.25% Rate Reset Preferred Shares (the “Series C Preferred Shares” and, together with the Series A Preferred Shares, the “Preferred Shares”). Pursuant to the Bids, the Company may repurchase on the open market (or as otherwise permitted), up to 22,455,925 Common Shares,...

Continue reading

Vallon Pharmaceuticals Announces Formation of Scientific Advisory Board

– Inaugural appointments include globally renowned leaders and experts on attention-deficit/hyperactivity disorder (ADHD) and stimulant abuse PHILADELPHIA, PA, Sept. 14, 2021 (GLOBE NEWSWIRE) — Vallon Pharmaceuticals, Inc. (NASDAQ: VLON), (“Vallon” or the “Company”), a clinical-stage biopharmaceutical company primarily focused on the development of novel drugs that are designed to deter abuse in the treatment of central nervous system (CNS) disorders, today announced the formation of and initial appointments to its Scientific Advisory Board (SAB). The SAB will guide and advise the Company as it advances its novel abuse-deterrent platform technology and its lead development programs ADAIR and ADMIR, which leverage the technology to resist manipulation for snorting and provide barriers to injection. David Baker, President and...

Continue reading

Macarthur Minerals receives in-principle ASX advice on suitability to list Infinity Mining Limited

VANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) — Macarthur Minerals Limited (TSX-V: MMS) (ASX: MIO) (OTCQB: MMSDF) (the Company or Macarthur) is pleased to announce that it has received in-principle advice on suitability from the Australian Securities Exchange which will enable Infinity Mining Limited (previously named Macarthur Lithium Pty Ltd) (Infinity) to advance plans for its listing on the Australian Securities Exchange (ASX) before the end of 2021. On 9 August 2021, Infinity lodged an application with ASX regarding its suitability for a proposed admission to the ASX Official List. On 9 September 2021, Infinity received “in-principle” advice from ASX which confirmed Infinity’s suitability for listing. Whilst the listing of Infinity is still subject to final exchange approvals, the receipt of this advice now...

Continue reading

Alain de Krassny Enters into Exclusive Negotiations with the Apollo Funds For the Sale of the Kem One Group

Alain de Krassny, President of the Kem One Group, announces his intention to sell Kem One to funds managed by affiliates of Apollo Global Management, with which he has entered into exclusive negotiations. After successfully transforming the business through a robust investment program, Mr. de Krassny believes Kem One is well-positioned for future growth under the ownership of the Apollo Funds. NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) — Alain de Krassny and Apollo Global Management (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”) declare that they have entered into exclusive negotiations for the sale of the Kem One Group to funds managed by affiliates of Apollo (the “Apollo Funds”). These discussions are taking place through De Krassny GmbH and the Apollo Funds. This proposed sale, for which the two parties signed...

Continue reading

SouthGobi Comments on Trading Activity at Request of IIROC

VANCOUVER, British Columbia, Sept. 14, 2021 (GLOBE NEWSWIRE) — SouthGobi Resources Ltd. (TSX: SGQ, HK: 1878) (“SouthGobi” or the “Company”) is issuing this announcement in response to a request from the Investment Industry Regulatory Organization of Canada (“IIROC”) to comment on the trading activity of the shares of the Company (the “Shares”) on the Toronto Stock Exchange on Monday, September 13, 2021. The Company is not aware of any material, undisclosed information related to the Company’s operations and affairs that would account for the recent increase in the market price and level of trading volume of the Shares or any information which must be announced to avoid a false market in the Company’s securities. Shareholders and potential investors of the Company are advised to exercise caution when dealing in the Shares. About...

Continue reading

CurrencyWorks’ Barrett-Jackson Las Vegas 2021 Rare Collector Series Edition Sell Out in Under an Hour

Los Angeles CA, Sept. 14, 2021 (GLOBE NEWSWIRE) — CurrencyWorks Inc. (“CurrencyWorks” or the “Company”), (CSE: CWRK and OTCQB: CWRK), a full service blockchain platform provider, is pleased to announce that Motoclub.io, a digital collectible space for automotive enthusiasts and fans of automotive memorabilia, successfully concluded its first drop of the Barrett-Jackson Las Vegas 2021 Collector Series SparkNFTs in less than an hour after release. In partnership with Barrett-Jackson, individual auction sales of historically and culturally significant vehicles were chosen for minting. Each is being featured across 5 SparkNFTs:1 x exclusive video 1 x custom illustration 3 x exclusive imagesThe chosen vehicles have been split into three series categories: Rare, Epic and Elite. The Elite pack drops will feature the most desirable...

Continue reading

P10 Holdings Announces Strategic Relationship with Crossroads, Inc. to Promote Impact Credit

DALLAS, Sept. 14, 2021 (GLOBE NEWSWIRE) — P10 Holdings, Inc. (OTC: PIOE) announces strategic relationship with Crossroads Systems, Inc. (OTCQX: CRSS) (“Crossroads”) to promote Impact Credit. P10’s Impact solution, Enhanced Capital Group, LLC, (“ECG”) announced a strategic partnership with Crossroads, parent company of Capital Plus Financial (“CPF”), a leading Certified Development Financial Institution (“CDFI”).  Under the terms of the agreement, ECG will originate and manage loans across its diverse lines of business including small business loans to women and minority owned businesses, and loans to renewable energy and community redevelopment projects.  The loans will be held by CPF, generating an attractive yield for CRSS while providing an advisory fee to ECG. Michael Korengold, CEO of Impact at P10, commented “Our 21-year...

Continue reading

Head Team Physician for the NFL Jacksonville Jaguars Dr. Kevin Kaplan Joins Draganfly Board of Advisors

Los Angeles, CA., Sept. 14, 2021 (GLOBE NEWSWIRE) — Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, is pleased to announce that Dr. Kevin Kaplan, head team physician for the NFL Jacksonville Jaguars, has joined as a member of the Board of Advisors to help further Draganfly’s Vital Intelligence AI (artificial intelligence) technology for health safety in school and sport settings. Dedicating more than a decade of his life to athlete care, Dr. Kaplan is currently the head team physician for the NFL Jacksonville Jaguars and has been a physician with the team for 12 years. He is also the head team physician for the Bolles School, where he graduated from in 1995. Previously, he served as the team physician for the Jacksonville...

Continue reading

OTC: ILUS, ILUS International (Ilustrato Pictures International Inc), to Present at the Emerging Growth Conference on 15 September, 2021

ILUS invites individual and institutional investors, as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference NEW YORK, NY, Sept. 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — ILUS International Inc (OTC: ILUS) is a Mergers and Acquisitions company focused on acquiring and developing public safety technology-based companies across the globe. ILUS is pleased to announce that it has been invited to present at the Emerging Growth Conference on 15 September, 2021. This live, interactive online event will give existing shareholders and the investment community the opportunity to interact with the Company’s Managing Director, John-Paul Backwell, in real time.  John-Paul Backwell will perform a presentation and may subsequently open the floor for questions. Please ask...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.